Indacaterol
CAS No. 312753-06-3
Indacaterol( QAB149 )
Catalog No. M14000 CAS No. 312753-06-3
Indacaterol(Onbrez; Arcapta) is an ultra-long-acting β-adrenoceptor agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
25MG | 39 | Get Quote |
|
50MG | 56 | Get Quote |
|
100MG | 83 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIndacaterol
-
NoteResearch use only, not for human use.
-
Brief DescriptionIndacaterol(Onbrez; Arcapta) is an ultra-long-acting β-adrenoceptor agonist.
-
DescriptionIndacaterol(Onbrez; Arcapta) is an ultra-long-acting β-adrenoceptor agonist.
-
In VitroCell Viability Assay Cell Line:HT1080 cells (constitutively express MMP-9)Concentration:1, 2.5, 5, 10 μM Incubation Time:12 h (pretreat)Result:Significantly suppressed MMP-9 mRNA expression in the 2.5 to 10 μM range.Cell Migration Assay Cell Line:HT1080 cells (constitutively express MMP-9)Concentration:10 μM Incubation Time:6 h (pretreat for 2 h, then incubat with TNF-α for 4 h)Result:Significantly reduced cell migration of fibrosarcoma and inhibited HT1080 cell migration in the zone of wound healing.Western Blot AnalysisCell Line:HT1080 cells Concentration:1, 2.5, 5, 10 μM Incubation Time:2.5 h (pretreat for 2 h, then incubat with TNF-α for 0.5 h)Result:Suppressed TNF-α induced the phosphorylation of IκBα and IKKα/β (the upstream activators of NF-κB).Inhibited TNF-α-induced NF-κB nuclear translocation when at 5 and 10 μM.Suppressed TNF-α-induced MMP-9 enzyme activity and decreased MMP-9 protein levels in a dose-dependent manner in the 2.5 to 10 μM range.
-
In VivoAnimal Model:Male Wistar rats (225-250 g; myocardial infarction (MI) rat model of heart failure (HF)).Dosage:0.3 mg/kg Administration:In animal drinking water; sinle daily for 15 weeks Result:Significantly reduced both mean arterial blood pressure and heart rate.Increased both systolic and diastolic LVID where in HF, and reversed the decreased ejection fraction (%) values.Significantly reduced the infarct size, and catecholamine values to basal levels.Significantly increased β1 mRNA expression and cardiac cAMP levels in respect to HF.
-
SynonymsQAB149
-
PathwayEndocrinology/Hormones
-
TargetAdrenergic Receptor
-
Recptorβ-adrenoceptor
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number312753-06-3
-
Formula Weight392.49
-
Molecular FormulaC24H28N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C1NC2=C(C([C@@H](O)CNC3CC4=C(C=C(CC)C(CC)=C4)C3)=CC=C2O)C=C1
-
Chemical Name5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Battram C, et al. J Pharmacol Exp Ther, 2006. 317(2): p. 762-70.
molnova catalog
related products
-
Droxidopa
Droxidopa is a psychoactive drug and acts as a prodrug to the neurotransmitters norepinephrine (noradrenaline) and epinephrine (adrenaline).
-
Carazolol
Carazolol is a high affinityantagonist/partial inverse agonist (also referred to as abeta blocker) of the β-adrenergic receptor.
-
Phenylephrine hydroc...
Phenylephrine hydrochloride is a selective α1-adrenergic receptor agonist.